A Study of TYRA-300 in Children With Achondroplasia: BEACH301
The BEACH301 study is exploring a new medication called TYRA-300 for children aged 3 to 10 who have achondroplasia. Achondroplasia is a condition that affects how bones grow, leading to shorter limbs. This study aims to understand if TYRA-300 is safe for children, how well their bodies handle it, and to identify the most effective dose. The children taking part still have 'open growth plates', which are areas in their bones where growth happens. This is a Phase 2 study, meaning it's an early step to gather more information after initial safety tests. The goal is to see if this medicine could help children with achondroplasia grow more effectively.
A colpo d'occhio
Di cosa tratta questo studio?
This study, known as BEACH301, is testing a new medicine called TYRA-300 for children who have a condition called achondroplasia. Achondroplasia is a genetic condition that affects how bones grow, particularly in the arms and legs, leading to shorter limbs. The study includes children aged 3 to 10 years old who still have 'open growth plates' – these are parts of their bones that are still growing.
The main goals of this study are to see if TYRA-300 is safe for children to take, how well their bodies tolerate it (meaning if they have uncomfortable side effects), and to figure out the right amount of medicine (the dose) that might be helpful. This is a 'Phase 2' study, which means it’s an important step in researching new medicines. It helps us learn more about the medicine's effects in people after initial safety checks.
Researchers are looking at different doses of TYRA-300 in this study. They hope to find a dose that could potentially help children with achondroplasia grow. The study is designed to carefully observe how children respond to the medicine and to gather crucial information for its future development.
Punti chiave
- This study is for children aged 3-10 with achondroplasia.
- It tests a new medicine, TYRA-300, taken by mouth.
- The main goals are to check safety, tolerability, and find the right dose.
- Children must have 'open growth plates' to join.
- Parents and children must agree to participate.
- Participation involves regular clinic visits and monitoring.
Chi può essere idoneo?
To join this study, children need to be between 3 and 10 years old. They must have a confirmed diagnosis of achondroplasia and still have 'open growth plates,' which are the areas in their bones that allow them to grow. It's also important that they can stand and walk by themselves and can take medicine by mouth.
There are a few specific groups within the study. Some children (aged 5-10) will be in a 'safety group' first. Others (aged 3-10) will either not have had any previous growth-boosting treatments, or they will have had such treatments in the past. Parents or legal guardians must give their permission for their child to take part, and if old enough, the child will also be asked if they want to participate.
Children cannot join the study if they have other serious health conditions that might interfere with the study or their growth, or if they have certain eye problems. Those who have had or plan to have limb-lengthening surgery, or who are taking certain other medications, also won't be able to participate.
Questo studio potrebbe fare al caso tuo?
Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.
- Is your child between 3 and 10 years old?
- Does your child have a confirmed diagnosis of achondroplasia?
- Does your child's doctor confirm they have 'open growth plates'?
- Can your child stand and walk on their own?
- Can your child take medicine by mouth?
- Has your child not had limb-lengthening surgery or planned for one soon?
Cosa comporta la partecipazione?
If your child takes part in this study, they will receive the study medicine, TYRA-300, which is taken by mouth. The study involves several visits to a clinic where doctors and nurses will check your child's health, measure their growth, and take blood samples to see how the medicine is working and to monitor for any side effects. These visits will help the researchers understand how safe the medicine is and what dose might be most effective.
Your child will be carefully monitored throughout the study. The study duration is not specified in detail, but it will involve regular check-ups and follow-up appointments. The medical team will explain the full schedule of visits and assessments before you decide to participate.
Rischi e benefici potenziali
Località (25)
- Lundquist Institute for Biomedical InnovationCodice postale verificatoTorrance, United States· Reclutamento
- Ospedale Pediatrico del ColoradoCodice postale verificatoAurora, Stati Uniti· Reclutamento
- Nemours Alfred I duPont Hospital for ChildrenCodice postale verificatoWilmington, United States· Reclutamento
- Johns Hopkins University School of MedicineCodice postale verificatoBaltimora, Stati Uniti· Reclutamento
- Uncommon CuresCodice postale verificatoChevy Chase, United States· Reclutamento
- University of MissouriCodice postale verificatoColumbia, United States· Reclutamento
- Washington UniversityCodice postale verificatoSt Louis, Stati Uniti· Reclutamento
- Duke University HospitalCodice postale verificatoDurham, Stati Uniti· Reclutamento
- Vanderbilt University Medical CenterCodice postale verificatoNashville, Stati Uniti· Reclutamento
- Children's Medical Center, DallasCodice postale verificatoDallas, Stati Uniti· Reclutamento
- University of Texas Health Science Center Medical School at HoustonCodice postale verificatoHouston, Stati Uniti· Reclutamento
- University of Wisconsin-MadisonCodice postale verificatoMadison, United States· Reclutamento
Domande comuni
What is achondroplasia?
Achondroplasia is a genetic condition that affects bone growth, leading to shorter arms and legs.
What does 'open growth plates' mean?
It means the areas in your child's bones where growth normally happens are still active and open.
Is TYRA-300 a pill?
Yes, TYRA-300 is a medicine that children will take by mouth.
What is a 'Phase 2' study?
It's an early stage of testing a new medicine in people to see if it's safe and if it works.
Will my child definitely grow taller in this study?
There's no guarantee the medicine will work for every child, as this study is still trying to find out if it is effective.
Come saperne di più
Lara Balick
Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.
Interessato a partecipare?
Discussione
Discussione della comunità
Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.